1. Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection
   Khursheed Muzammil et al, 2024, Microbial Cell Factories CrossRef
2. Insight into the Evolving Role of PCSK9
   Mateusz Maligłówka et al, 2022, Metabolites CrossRef
3. Hyperlipidemia, statin use and dengue severity
   Po Ying Chia et al, 2018, Scientific Reports CrossRef
4. Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds
   Je-Wen Liou et al, 2022, International Journal of Molecular Sciences CrossRef
5. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
   Rami A. Al-Horani et al, 2020, International Journal of Molecular Sciences CrossRef
6. Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
   María I. Zapata-Cardona et al, 2022, Frontiers in Microbiology CrossRef
7. Dengue virus induces PCSK9 expression to alter antiviral responses and disease outcomes
   Esther Shuyi Gan et al, 2020, Journal of Clinical Investigation CrossRef
8. Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
   Supreeti Mahajan et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
9. The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions
   Marijke Verhaegen et al, 2024, npj Viruses CrossRef
10. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
    Mohd Ishtiaq Anasir et al, 2020, Viruses CrossRef
11. [18F]Atorvastatin: synthesis of a potential molecular imaging tool for the assessment of statin-related mechanisms of action
    Gonçalo S. Clemente et al, 2020, EJNMMI Research CrossRef
12. Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids
    Manuel Torres et al, 2021, Membranes CrossRef
13. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility
    Tarek Kashour et al, 2021, Immunopharmacology and Immunotoxicology CrossRef
14. A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
    Luis Adrián De Jesús-González et al, 2024, Microorganisms CrossRef
15. Recent advances in antiviral drug development towards dengue virus
    Berit Troost et al, 2020, Current Opinion in Virology CrossRef
16. An ivermectin – atorvastatin combination impairs nuclear transport inhibiting dengue infection in vitro and in vivo
    Selvin Noé Palacios-Rápalo et al, 2023, iScience CrossRef
17. Lipids in infectious diseases – The case of AIDS and tuberculosis
    Fabrice Dumas et al, 2017, Biochimica et Biophysica Acta (BBA) - Biomembranes CrossRef
18. Lipophilic statins inhibit Zika virus production in Vero cells
    Erica Españo et al, 2019, Scientific Reports CrossRef
19. The role of lovastatin in the attenuation of COVID-19
    Sajad Karampoor et al, 2021, International Immunopharmacology CrossRef
20. МНОЖЕСТВЕННОСТЬ БИОЛОГИЧЕСКИХ ЭФФЕКТОВ СТАТИНОВ И ЕЕ ЗНАЧЕНИЕ В УТОЧНЕНИИ ПАТОГЕНЕЗА АТЕРОСКЛЕРОЗА, "Успехи современной биологии"
    Н. Н. Плужников et al, 2018, Успехи современной биологии CrossRef
21. Cellular Cholesterol Facilitates the Postentry Replication Cycle of Herpes Simplex Virus 1
    George A. Wudiri et al, 2017, Journal of Virology CrossRef
22. LDL receptor and pathogen processes: Functions beyond normal lipids
    Jairo Aldana-Bitar et al, 2021, Journal of Clinical Lipidology CrossRef
23. Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections
    Juan Fidel Osuna-Ramos et al, 2023, Viruses CrossRef
24. Anti-flavivirus Properties of Lipid-Lowering Drugs
    Carlos Noe Farfan-Morales et al, 2021, Frontiers in Physiology CrossRef
25. Serine protease inhibitor AEBSF reduces dengue virus infection via decreased cholesterol synthesis
    Liji Sreelatha et al, 2019, Virus Research CrossRef
26. Novel Antiviral Strategies Against Emerging Arbovirus Infections
    Yannick Brüggemann et al, 2022, New Drug Development for Known and Emerging Viruses CrossRef
27. AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells
    Devendra Nath Tewari et al, 2023, Virology CrossRef
28. The Role of Host Cholesterol During Flavivirus Infection
    Juan Fidel Osuna-Ramos et al, 2018, Frontiers in Cellular and Infection Microbiology CrossRef
29. Targeting host lipid flows: Exploring new antiviral and antibiotic strategies
    Alberto Fernández-Oliva et al, 2019, Cellular Microbiology CrossRef